LONA
LeonaBio, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$79.75M
P/E Ratio
—
EPS
$-24.09
Beta
1.98
52W High
$14.21
52W Low
$2.85
50-Day MA
$9.49
200-Day MA
$6.31
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About LeonaBio, Inc.
LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company is headquartered in Bothell, Washington.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-41.83M |
| Operating Margin | 0.00% |
| Return on Equity | -298.80% |
| Return on Assets | -46.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.98 |
| Price-to-Book | 1.62 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.31 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $9.39M |
| Float | $6.41M |
| % Insiders | 4.51% |
| % Institutions | 70.35% |
Historical Volatility
HV 10-Day
42.39%
HV 20-Day
58.88%
HV 30-Day
62.19%
HV 60-Day
86.61%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($18.00 target)
1
Strong Buy2
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026